LU7
0.014
40%
CNJ
0.004
-42.9%
SNS
0.088
35.4%
PPY
0.009
-35.7%
AMS
0.008
33.3%
HCD
0.002
-33.3%
THR
0.013
30%
TMX
0.002
-33.3%
PLG
0.023
27.8%
XGLR
0.002
-33.3%
ZMM
0.015
25%
RNX
0.003
-25%
SPL
0.135
22.7%
CXU
0.007
-22.2%
ILA
0.28
21.7%
JAL
0.1
-20%
FAU
0.006
20%
FMR
0.4
-18.4%
GBZ
0.036
20%
PNT
0.009
-18.2%
MOH
0.006
20%
LOT
0.185
-17.8%
SRL
2
19.8%
FZR
0.14
-17.6%
4DX
1.365
18.2%
FAL
0.86
-17.3%
RCR
0.02
17.6%
BPP
0.005
-16.7%
AVE
0.007
16.7%
NTD
0.295
-14.5%
CTO
0.007
16.7%
ARV
0.006
-14.3%
LML
0.007
16.7%
BNL
0.006
-14.3%
OEC
0.245
16.7%
ECS
0.006
-14.3%
PVW
0.021
16.7%
VRL
0.024
-14.3%
SMM
0.014
16.7%
GDM
0.345
-13.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf